At her first EU summit since Britain's vote to leave the bloc, UK prime minister Theresa May tries to reassure EU leaders over Brexit - but is told by French President Francois Hollande to prepare for tough negotiations. Julian Satterthwaite reports.
Disney reported its fiscal second quarter earnings before the bell on Tuesday. Here's what to know.
Ride-hailing company Lyft projected higher-than-expected gross bookings and core profit for the current quarter on Tuesday, driven by robust demand for its services and benefits from new user and driver features. Lyft has been luring consumers with shortened wait times for some pre-scheduled rides and drivers with minimum wage guarantees while trimming costs to boost profitability. Since CEO David Risher took charge last April, the company has cut hundreds of jobs, reduced the firm's losses, and managed to keep fare increases in check.
Oscar Health stock rocketed near a profit-taking zone Tuesday after the health insurer crushed forecasts in its first-ever quarter of profits.
The child's body was recovered the next day
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
PINE MOUNTAIN, Georgia, May 07, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA) (“Parks! America” or the “Company”), a leading operator of regional safari parks in the United States. Dear Parks! America Shareholders, On April 23, 2024, we filed our proxy statement for the upcoming June 6, 2024 Parks! America, Inc. (“PRKA” or the “Company”) Annual Meeting of Stockholders, and the mailing of the proxy commenced on April 26, 2024. Please read the information in this proxy carefully an
SAN FRANCISCO, May 07, 2024--Nextdoor appoints Marissa Mayer, Niraj Shah, and Robert Hohman to Board of Directors.
COLUMBUS, Ohio., May 07, 2024--Intellinetics, Inc. (NYSE American: INLX), a digital transformation solutions provider, today announced that it will report its financial results for the first quarter of 2024, the period ended March 31, 2024, on Tuesday, May 14, 2024, after the close of the market.
Results from Disney took center stage as the media giant posted the first profit for a key part of its streaming business.
JOHANNESBURG, South Africa, May 07, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka”) has signed a definitive agreement to acquire Adumo RF (Pty) Ltd (“Adumo”) for ZAR 1.59 billion ($85.9 million translated at the prevailing rate $1: ZAR 18.50 as of May 7, 2024). The transaction is subject to shareholder and regulatory approvals. The purchase consideration1 will be settled through the combination of an issuance of 17,279,803 shares of Lesaka common stock to A
TEL AVIV, Israel, May 07, 2024--Similarweb Ltd. (NYSE: SMWB) ("Similarweb" or the "Company"), a leading digital data and analytics company powering critical business decisions, today announced financial results for its first quarter ended March 31, 2024. The Company published a letter to shareholders from management discussing these results, which can be accessed at the link: https://ir.similarweb.com/financials/quarterly-results, located on the Company's investor relations website.
-- Advancing CB-010 ANTLER Phase 1 trial in 2L LBCL; initial dose expansion data to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting -- -- Expanding into autoimmune diseases with IND cleared for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 -- -- Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple milestones ahead -- -- $345.9 million in cash, cash
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, President and Chief Executive Officer, and Darrel P. Cohen, M.D., Ph.D., Chief Medical Officer, are scheduled to participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 11:00
BOSTON, May 07, 2024--Semrush Holdings, Inc. (NYSE: SEMR), a leading online visibility management SaaS platform, will present and host one-on-one investor meetings at the following investor conferences:
HAYWARD, Calif., May 07, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and financial results for the first quarter ended March 31, 2024.
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First quarter 2024 revenue was $566.7 million, compared to $568.6 million in the same period in the prior year. GAAP gross profit for the first quarter of 2024 was $185.2 million, as compared to $192.0 million in the same
– Q1 2024 revenue of $21.1 million excluding discontinued operations and NY increased 44.5% year-over-year – – Submitted a substantial legal filing on May 2nd in the ongoing litigation with Verano – – Company announces launch of Hi*AF and Boundary Waters branded beverages – MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great va
– Enrollment completed for Phase 2 trial evaluating iluzanebart in ALSP; Next data readout planned for Q3 2024 – – Phase 1 healthy volunteer trial evaluating VG-3927 for Alzheimer’s disease ongoing; Interim data analysis on track for mid-2024 – WATERTOWN, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced financial re
Q1 Revenue Grew to $43.0 Million, Surpassing 91% Recurring Revenue GAAP Gross Margin Expands to 67%; Adjusted Gross Margin Rises to 76% Streamlined Operations Improve Profitability with Net Income Increasing by $15.7 Million Year-Over-Year; EPS Improved to $0.23 from $(1.39) in Q1 2023; Adjusted EBITDA Improved 78% to $10.9 Million Company Reaffirms 2024 Guidance BRIDGEWATER, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a g
Results for the Quarter Ended March 31, 2024 and Other Recent Highlights: Net investment income per share for the quarter was $0.44, compared to $0.46 for the quarter ended December 31, 2023 Net asset value per share as of the end of the quarter was $15.42, compared to $15.41 as of December 31, 2023 New investment commitments made during the quarter totaled $149 million(1) Gross fundings, excluding revolver fundings(2), totaled $129 million for the quarter Net fundings, including revolvers(2), t
Yahoo Finance